BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17402991)

  • 21. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
    Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
    Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
    Milić S; Stimac D
    Dig Dis; 2012; 30(2):158-62. PubMed ID: 22722431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric nonalcoholic fatty liver disease.
    Lerret SM; Skelton JA
    Gastroenterol Nurs; 2008; 31(2):115-9. PubMed ID: 18391799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic Fatty liver disease and obesity.
    Saadeh S
    Nutr Clin Pract; 2007 Feb; 22(1):1-10. PubMed ID: 17242448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease in children.
    Mager DR; Roberts EA
    Clin Liver Dis; 2006 Feb; 10(1):109-31, vi-vii. PubMed ID: 16376797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in nonalcoholic fatty liver disease-related hospitalizations in US children, adolescents, and young adults.
    Koebnick C; Getahun D; Reynolds K; Coleman KJ; Porter AH; Lawrence JM; Punyanitya M; Quinn VP; Jacobsen SJ
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):597-603. PubMed ID: 19412009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
    Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
    Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease in the pediatric population.
    Lavine JE; Schwimmer JB
    Clin Liver Dis; 2004 Aug; 8(3):549-58, viii-ix. PubMed ID: 15331063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease in children.
    Alisi A; Locatelli M; Nobili V
    Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):397-402. PubMed ID: 20531177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
    Lu H; Zeng L; Liang B; Shu X; Xie D
    Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.
    Chitturi S; Farrell GC; Hashimoto E; Saibara T; Lau GK; Sollano JD;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):778-87. PubMed ID: 17565630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
    Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
    Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.
    Patton HM; Sirlin C; Behling C; Middleton M; Schwimmer JB; Lavine JE
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):413-27. PubMed ID: 17033514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease.
    Papandreou D; Karabouta Z; Pantoleon A; Rousso I
    Appetite; 2012 Dec; 59(3):939-44. PubMed ID: 23000278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease in India--is it different?
    Duseja A
    Trop Gastroenterol; 2006; 27(4):142-6. PubMed ID: 17542290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.